CytoDyn Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Summary of Fair Value Derivative Liability and Linked Common Shares (Detail)

Summary of Fair Value Derivative Liability and Linked Common Shares (Detail) (USD $)

Nov. 30, 2014

Sep. 26, 2014

Derivative [Line Items]

Total derivative liability

$ 1,572,613

^[1]

$ 767,038

Shares indexed to derivative liability

2,000,000

[1]	The Company did not have any assets or liabilities measured at fair value using Level 1 or 2 of the fair value hierarchy as of November 30, 2014 and May 31, 2014.

- Definition

Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.

+ References + Details